Skip to main content
. 2021 Sep 20;17(7):569–575. doi: 10.4244/EIJ-D-20-00853

Table 3. Comparison of individual MACE events between patients with and without CMD.

All patients N=610 CMD– N=340 CMD+ N=270 p-value
Composite MACE, n (%) 174 (29) 83 (24) 91 (34) 0.01
Death, n (%) 96 (16) 45 (13) 51 (19) 0.06
Myocardial infarction, n (%) 35 (6) 17 (5) 18 (7) 0.38
Revascularisation, n (%) 38 (6) 19 (6) 19 (7) 0.46
Stroke, n (%) 30 (5) 14 (4) 16 (6) 0.31
CFR: coronary flow reserve; HMR: hyperaemic microvascular resistance; MACE: major adverse cardiovascular events